271 results Aan de slag met de nieuwe Wet hergebruik van overheidsinformatie Op 18 juli 2015 is de Wet hergebruik van overheidsinformatie (de "Who") in werking getreden. Burgers en bedrijven kunnen bij publieketaakinstellingen een verzoek indienen tot het verstrekken van overheidsinformatie. Stibbe advises Insight Stibbe advises Insight Venture Partners on the acquisition of a minority stake in DataSnipper. Insight Venture Partners is a New York private equity fund that invests in high-growth technology and software companies. Getting the Deal Through - Private M&A 2023: The BeNeLux chapters A team of Stibbe lawyers from our Brussels, Luxembourg and Amsterdam offices have authored the BeNeLux sections of the Private M&A 2023 chapters published by Lexology Getting the Deal Through. Clémence Jonckheere Junior Associate Brussels Product counseling en intellectueel eigendom In deze podcastaflevering van Stibbe Legal Insights spreken Femke van der Voort, gespecialiseerd in intellectueel eigendom, en Paul van der Hulst, mede-eigenaar en managing director van MoviĜo, over het beschermen van intellectuele eigendomsrechten. Lila Kadri Associate Luxembourg Nicolas Maraval Associate Luxembourg Guillaume Collé Associate Luxembourg Marie-Loo Giltaire Junior Associate Luxembourg Frédéric Playe Associate Luxembourg Stibbe advises Aedifica Stibbe has advised Aedifica on the acquisition and lease of a care residence to be constructed in Lelystad and the acquisition and lease of a recently completed care residence in Zwolle. Stibbe advises Aquiline Capital Partners Stibbe advised Aquiline Capital Partners, a private equity firm based in New York investing in financial services enterprises, as lead counsel on the acquisition of the Quintes group together with existing management. Breaking news from the CJEU: no SPCs for new therapeutic applications On 9 July 2020, the Grand Chamber of the CJEU ruled on the interpretation of Article 3(d) of Regulation 469/2009 concerning the supplementary protection certificate (CCP) for medicinal products. Stibbe advises The Blackstone Group Advising The Blackstone Group on the acquisition - and on the structuring and financing of this acquisition - of a logistics property portfolio in the Netherlands and Germany from Syntrus Achmea Real Estate Investment Fund. Stibbe advises selling shareholders of Punch Powertrain Stibbe assisted the selling shareholders of Punch Powertrain on the sale of their participation to New Horizon Capital. Stibbe advises Lampiris Stibbe advised Lampiris and its reference shareholders throughout the auction process organised by BNP Paribas Fortis up to signing the legal documentation with Gimv and SRIW, the ultimate preferred bidders who invested EUR 40 million in Lampiris. Stibbe advises group of investors led by Joh. A. Benckiser Stibbe advised a group of investors led by Joh. A. Benckiser on its bid for all outstanding shares of D.E MASTER BLENDERS 1753 N.V. Stibbe advises leading pharmaceutical company Stibbe assisted a leading pharmaceutical company in identifying the most cost-effective way to obtain in Belgium an improved pricing and reimbursement for new fixed-dose combination products composed of off-patent ingredients. Pagination Previous page Page 10 Current page 11 Page 12 Page 13 Next page
Aan de slag met de nieuwe Wet hergebruik van overheidsinformatie Op 18 juli 2015 is de Wet hergebruik van overheidsinformatie (de "Who") in werking getreden. Burgers en bedrijven kunnen bij publieketaakinstellingen een verzoek indienen tot het verstrekken van overheidsinformatie.
Stibbe advises Insight Stibbe advises Insight Venture Partners on the acquisition of a minority stake in DataSnipper. Insight Venture Partners is a New York private equity fund that invests in high-growth technology and software companies.
Getting the Deal Through - Private M&A 2023: The BeNeLux chapters A team of Stibbe lawyers from our Brussels, Luxembourg and Amsterdam offices have authored the BeNeLux sections of the Private M&A 2023 chapters published by Lexology Getting the Deal Through.
Product counseling en intellectueel eigendom In deze podcastaflevering van Stibbe Legal Insights spreken Femke van der Voort, gespecialiseerd in intellectueel eigendom, en Paul van der Hulst, mede-eigenaar en managing director van MoviĜo, over het beschermen van intellectuele eigendomsrechten.
Stibbe advises Aedifica Stibbe has advised Aedifica on the acquisition and lease of a care residence to be constructed in Lelystad and the acquisition and lease of a recently completed care residence in Zwolle.
Stibbe advises Aquiline Capital Partners Stibbe advised Aquiline Capital Partners, a private equity firm based in New York investing in financial services enterprises, as lead counsel on the acquisition of the Quintes group together with existing management.
Breaking news from the CJEU: no SPCs for new therapeutic applications On 9 July 2020, the Grand Chamber of the CJEU ruled on the interpretation of Article 3(d) of Regulation 469/2009 concerning the supplementary protection certificate (CCP) for medicinal products.
Stibbe advises The Blackstone Group Advising The Blackstone Group on the acquisition - and on the structuring and financing of this acquisition - of a logistics property portfolio in the Netherlands and Germany from Syntrus Achmea Real Estate Investment Fund.
Stibbe advises selling shareholders of Punch Powertrain Stibbe assisted the selling shareholders of Punch Powertrain on the sale of their participation to New Horizon Capital.
Stibbe advises Lampiris Stibbe advised Lampiris and its reference shareholders throughout the auction process organised by BNP Paribas Fortis up to signing the legal documentation with Gimv and SRIW, the ultimate preferred bidders who invested EUR 40 million in Lampiris.
Stibbe advises group of investors led by Joh. A. Benckiser Stibbe advised a group of investors led by Joh. A. Benckiser on its bid for all outstanding shares of D.E MASTER BLENDERS 1753 N.V.
Stibbe advises leading pharmaceutical company Stibbe assisted a leading pharmaceutical company in identifying the most cost-effective way to obtain in Belgium an improved pricing and reimbursement for new fixed-dose combination products composed of off-patent ingredients.